Burling Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History

Burling Wealth Partners’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$609K	Sell	1,239 -74	-6%	-$40.2K	0.1%	115
2025 Q4	$761K	Buy	1,313 +648	+97%	+$366K	0.12%	109
2025 Q3	$323K	Sell	665 -128	-16%	-$59.6K	0.05%	147
2025 Q2	$322K	Sell	793 -145	-15%	-$60.6K	0.06%	147
2025 Q1	$467K	Sell	938 -38	-4%	-$20.6K	0.1%	118
2024 Q4	$508K	Buy	+976	New	+$537K	0.1%	121

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Burling Wealth Partners's TMO Position: Q1 2026 in Review

Burling Wealth Partners reduced its Thermo Fisher Scientific (TMO) stake by 5.6% in Q1 2026, selling an estimated $40.2K and leaving 1,239 shares worth $609K. The position accounts for 0.1% of the portfolio, ranked #115.

Burling Wealth Partners first reported a position in TMO in Q4 2024 and has held it in 6 quarters since. The position peaked at $761K in Q4 2025. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Burling Wealth Partners held 1,239 shares of Thermo Fisher Scientific worth $609K as of Q1 2026.
Burling Wealth Partners sold 74 Thermo Fisher Scientific shares in Q1 2026, an estimated $40.2K.
Thermo Fisher Scientific made up 0.1% of Burling Wealth Partners's portfolio in Q1 2026, its #115 holding.
Burling Wealth Partners first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 6 quarters since.
Burling Wealth Partners's Thermo Fisher Scientific position peaked at $761K in Q4 2025.
2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Burling Wealth Partners's 13F filing for Q1 2026, filed 8 May 2026.